Congress mandates ovarian cancer genetic testing coverage, funds rural outreach
H.R. 10544 — To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes. · Filed by Rosa DeLauro (D-CT) · 3 cosponsors · Introduced Sep 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands federal programs to improve ovarian cancer prevention, detection, and treatment by funding public awareness campaigns, genetic counseling and testing, and specialty care access—particularly in rural and underserved communities. It requires health insurance plans to cover genetic testing, counseling, and risk-reducing surgeries for people at hereditary risk of ovarian cancer, and authorizes $20 million annually through 2031 for demonstration projects and outreach.
Why we flagged it
The bill's operative mechanism is a straightforward expansion of federal health programs and insurance coverage mandates aimed at improving ovarian cancer prevention and early detection in underserved populations. It is not a tax provision, subsidy to a named entity, or deregulation—it is affirmative public health policy.
What the text implies
- Insurance cost-shifting: while the bill mandates coverage, it does not cap out-of-pocket costs (deductibles, copays) for genetic testing or counseling—patients may still face barriers despite the mandate.
- Provider capacity constraints: the bill funds awareness and demonstration projects but does not directly fund hiring or training of genetic counselors, who are already in short supply; rural access gains may be limited by supply-side bottlenecks.
- Telehealth reliance: genetic counseling 'in person or via telehealth' may expand access, but rural broadband gaps and digital literacy barriers could limit uptake in the communities the bill targets.
- Employer plan variation: the bill applies to group and individual plans but grandfathered plans (Section 1251) are subject to different rules; coverage uniformity across plan types is not guaranteed.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill expands access to preventive genetic testing, counseling, and risk-reducing care for people at hereditary ovarian cancer risk—populations currently facing disparities in rural and underserved areas. Insurance coverage mandates reduce out-of-pocket barriers to early detection and prevention. Public education and provider training improve awareness and appropriate referrals, benefiting patients and families.
Who stands to gain
- genetic testing laboratories and diagnostic companies
- genetic counseling service providers
- academic medical centers and specialty oncology practices
- rural hospitals and community health centers (grant recipients)
Named in the bill
Department of Health and Human Services, Centers for Disease Control and Prevention, Health Resources and Services Administration, National Cancer Institute, National Comprehensive Cancer Network, American Society of Clinical Oncology, Society of Gynecologic Oncology, Public Health Service Act, Patient Protection and Affordable Care Act
Where it stands
3 cosponsors: 2 Republicans, 1 Democrats.
- Sep 24, 2026 — Introduced · Congress.gov: “Introduced in House”
- Sep 24, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (12,938 characters) on Oct 28, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,595 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-28.
“Congress mandates ovarian cancer genetic testing coverage, funds rural outreach” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10544 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.